Bacillus Calmette-Guerin lymphadenitis: A 6-year experience in two Saudi hospitals.
Indian J Pathol Microbiol
;
2012 Apr-Jun 55(2): 202-205
Artigo
em Inglês
| IMSEAR
| ID: sea-142222
ABSTRACT
Background:
The World Health Organization (WHO) has recommended Bacillus Calmette-Guerin (BCG) vaccination as a part of the global expanded program for immunization. Although the BCG vaccine is usually a safe vaccine, a number of complications with lymphadenitis being the most common complication, can occur.Aim:
We evaluated the frequency, the clinical presentation and treatment modalities of lymphadenitis after BCG vaccine in Saudi children.Results:
A total of 145 patients with BCG lymphadenitis presented between January 2005 and December 2010. In the majority (103) of the cases, the lymphadenitis involved ipsilateral left axillary nodes. Other sites of involvement included the left supraclavicular lymph nodes in 26 (18%) patients, and both the left axillary and supraclavicular lymph nodes were involved in 7 cases (4.8%). A total of 75 patients (65%) were given antituberculous medication. Eight (27%) patients had positive acid-fast bacilli and positive cultures for Mycobacterium bovis.Conclusion:
In light of the findings of this study, it would be advisable to administer the BCG vaccine in Saudi Arabia at a time later than at birth, as the younger children are commonly affected.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Arábia Saudita
/
Humanos
/
Masculino
/
Vacina BCG
/
Prevalência
/
Fatores Etários
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Hospitais
/
Lactente
/
Linfadenite
Tipo de estudo:
Estudo de prevalência
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Indian J Pathol Microbiol
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS